Active targeting of chemotherapy to disseminated tumors using nanoparticle-carrying T cells. [electronic resource]
Producer: 20160307Description: 291ra94 p. digitalISSN:- 1946-6242
- Animals
- Antineoplastic Agents -- pharmacology
- Bystander Effect -- drug effects
- Camptothecin -- analogs & derivatives
- Cell Line, Tumor
- Cell Movement
- Cell Proliferation -- drug effects
- Cytotoxicity, Immunologic -- drug effects
- Drug Delivery Systems -- methods
- Humans
- Interleukin-2 -- pharmacology
- Irinotecan
- Lymph Nodes -- drug effects
- Lymphoma -- drug therapy
- Mice
- Nanocapsules -- chemistry
- Nanoparticles -- chemistry
- Receptors, Lymphocyte Homing -- metabolism
- Sirolimus -- pharmacology
- T-Lymphocytes -- drug effects
- Treatment Outcome
No physical items for this record
Publication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, Non-P.H.S.
There are no comments on this title.
Log in to your account to post a comment.